Bristol Myers Squibb (NYSE: BMY) strengthens Camzyos growth case with positive adolescent SCOUT-HCM data
Read More Pharma Industry News Novartis gets Leqvio FDA approval for reducing bad cholesterol levels Novartis has secured approval from the US Food and Drug Administration (FDA) for its small interfering RNA (siRNA)… bySrinathJanuary 2, 2022
